Affiliation:
1. Military Medical Academy n. a. S.M. Kirov, St. Petersburg, Russian Federation
Abstract
Abstract: Relevance. The use of nitroglycerin (NG) in cardiogenic shock (СS) helps to normalize blood pressure, reduce the risk of death and improve prognosis.
Aim. To study the effect of vasopressors, inotropic drugs and nitroglycerin on hemodynamics and reducing the risk of death in patients with cardiogenic shock.
Material and methods. A comparative assessment of the effectiveness of treatment of СS in myocardial infarction with nitroglycerin and traditional approaches to therapy was carried out. In the control group of patients with СS (17 people), dopamine or norepinephrine was administered in the traditional way. In the main group of patients with СS (22 people), large doses of nitroglycerin were administered. After the stabilization of the state of health, the drip injection of NG continued in the usual doses.
Results. In 20 of 22 patients of the main group, immediately after the jet injection of nitroglycerin, blood pressure began to be determined or significantly increased, 14 of them survived (63.6%). In 9 cases, blood pressure did not decrease anymore, vasopressors were not administered, nitroglycerin was administered by drop for another 2-3 days, the treatment ended with discharge in a satisfactory state. In another 2 cases, it was necessary to administer vasopressors in parallel with the drip administration of nitroglycerin, after its jet administration. In the control group, the only patient survived (5.9%).
Conclusions. Analysis of literature data indicates that in conditions of maximum depletion of reserves and a decrease in myocardial contractility in patients with cardiogenic shock, the use of vasopressors and inotropic drugs accelerates the decompensation of insufficient blood supply and increases the risk of death. The main way to combat СS is still urgent myocardial revascularization, however, the restoration of the functional activity of hibernated cardiomyocytes will be more successful and safer with their gradual activation. This problem can be successfully solved using the methods of mechanical support of blood circulation or with the help of nitroglycerin. It will be possible to verify the validity of this assumption only on the basis of the results of randomized clinical trials.
Reference15 articles.
1. Reynolds H.R., Hochman J.S. Cardiogenic shock: current concepts and improving outcomes // Circulation. 2008. Vol.117, Р. 686-697. doi: 10.1161/circulation aha.106.613596
2. Sotnikov A.V., Epifanov S.Ju., Kudinova A.N., Gordienko A.V., Nosovich D.V. Clinical features of myocardial infarction with reinfarction and early post-infarction angina among men younger than 60 years // Medical & pharmaceutical journal "Pulse". 2019. Т.21. №9. P. 29-36. doi: 10.26787/nydha-2686-6838-2019-21-9-29-36
3. Xiushui M.R., Lenneman A. Cardiogenic Shock. 2019. https://emedicine.medscape.com/article/152191-overview 06
4. Nosovich D.V., Yakovlev V.V., Sotnikov A.V. 8.22. Features of the clinical course, complications and outcomes of primary and repeated myocardial infarction in men younger than 60 years, depending on the presence of arterial hypertension. III Evrazijskij kongress kardiologov: sbornik tezisov. M.: OOO "InterMedservis"; 2014: 68-69.
5. Gordienko A.V., Sotnikov A.V., Nosovich D.V. Seasonal features of myocardial infarction in men of young and middle age. The Journal of scientific articles “Health and Education Millenium”. 2017. Vol.19, №10. Р: 65-70.